Trials / Completed
CompletedNCT03684096
Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes
The Effect of the Non-estrogenic Pollen Extract PCC-100 on Hot Flushes During Adjuvant Hormonal Treatment for Breast Cancer in Postmenopausal Women and in Menopausal Women Without a History of Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- Female
- Age
- 50 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Many postmenopausal women have vasomotor symptoms during adjuvant hormonal treatment for breast cancer. PCC-100 is a pollen extract used for alleviation of postmenopausal symptoms. In a randomised, double blinded study pollen extract PCC-100 will be used to treat vasomotor complaints in postmenopausal women under adjuvant hormonal treatment and also in menopausal women without a history of breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | non-estrogenic pollen extract PCC-100 | non-estrogenic pollen extract PCC-100 |
| OTHER | placebo | placebo -non-estrogenic pollen extract PCC-100 |
Timeline
- Start date
- 2018-10-15
- Primary completion
- 2023-01-31
- Completion
- 2023-01-31
- First posted
- 2018-09-25
- Last updated
- 2024-02-15
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03684096. Inclusion in this directory is not an endorsement.